Actively Recruiting
Rarecells Molecular Biomarkers for Early Detection of Lung Cancer
Led by Rarecells Diagnostics SAS · Updated on 2025-06-11
50
Participants Needed
1
Research Sites
46 weeks
Total Duration
On this page
Sponsors
R
Rarecells Diagnostics SAS
Lead Sponsor
M
Meditrial Europe Ltd.
Collaborating Sponsor
AI-Summary
What this Trial Is About
Early diagnosis of lung cancer is a public health priority. Additionally, early detection of recurrences after treatment is crucial for optimizing disease management. This study seeks to demonstrate the accuracy of the Rarecells ISET® circulating tumor cells DNA (CTC-DNA), combined with circulating tumor DNA (ctDNA), for the early diagnosis of lung cancer.
CONDITIONS
Official Title
Rarecells Molecular Biomarkers for Early Detection of Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged between 35 and 85 years
- Patient diagnosed with resectable lung cancer (by imaging and/or pathological examination) not yet treated for this cancer
- Patient capable of giving free, informed, and express consent
- Exclusion of detectable extra thoracic and distant metastases
- Determination of the presence or absence of superior mediastinal lymph node metastases
- Definition of the histologic or cell type, whenever possible
- Evaluation of operative risk
You will not qualify if you...
- Patient diagnosed and/or treated previously for lung cancer or another cancer, regardless of duration
- Patient treated with neoadjuvant treatment
- Pregnant women
- Patient presenting psychiatric or neurological disorders preventing them from understanding the research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Università Cattolica del Sacro Cuore Gemelli Hospital
Roma, Italy
Actively Recruiting
Research Team
M
Monica Tocchi, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here